Normal view MARC view ISBD view

[The pathogenetic bases of the medical procedure for promoting the health of frequently ill children attending preschool institutions]. [electronic resource]

By:

Andreeva, E I

Contributor(s):

Musina, B K

Producer: 19910131Description: 63-7 p. digitalISSN:

0031-403X

Subject(s):

In: Pediatriia no. 9

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

121 Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery.
by Miyata, Kohei
122 Effects of exendin-4 on colonic motility in rats and its underlying mechanism.
by Yan, Lin
123 [Treatment with new preparations against type 2 diabetes not sufficiently documented].
by Karlsson, Eva Andersén
124 Exenatide: excessive weight loss.
125 Exenatide extended-release: a once-weekly option for patients with type 2 diabetes.
by Anderson, Zachary L
126 Potential side effects to GLP-1 agonists: understanding their safety and tolerability.
by Consoli, Agostino
127 Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration.
by Rachmany, Lital
128 GLP-1 agonist associated acute kidney injury: A case report and review.
by Sharma, T
129 Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
by Idzerda, Nienke M A
130 Exendin-4, a GLP-1 receptor agonist regulates retinal capillary tone and restores microvascular patency after ischaemia-reperfusion injury.
by Zhai, Ruyi
131 Is exenatide advancing the treatment of type 2 diabetes?
by Doggrell, Sheila A
132 Diabetes basics. Exenatide and pramlintide. New meds on the block.
by Griffin, Stacy
133 Action of GLP-1 (7-36) amide and exendin-4 on Suncus murinus (house musk shrew) isolated ileum.
by Chan, Sze Wa
134 Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.
by Swedberg, Joakim E
135 A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA(1c)) on exenatide treatment.
by Brooks, A M S
136 American diabetes association - 65th Scientific Sessions.
by Erlich, Rebecca
137 Incretin mimetics as a novel therapeutic option for hepatic steatosis.
by Tushuizen, Maarten E
138 Exenatide enhances INS-1 rat pancreatic β‑cell mass by increasing the protein levels of adiponectin and reducing the levels of C-reactive protein.
by Quan, Huibiao
139 The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice.
by Thomsen, Morgane
140 [Reply on new drugs against type 2 diabetes: important to gain experience and knowledge].
by Sjöholm, Ake